NASDAQ · Medical - Devices

Inogen, Inc (INGN) Stock

$7.10 +0.85% NASDAQ: INGN Healthcare

Valuation

MetricValue
Price$7.10
Market Cap$188.42M
P/E Ratio-6.57
P/B Ratio0.91
P/S Ratio0.45
EPS (TTM)$-0.85
52-Week High$9.13
52-Week Low$5.04
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-13.17%
ROA-8.61%
ROCE-13.94%
Gross Margin-8.60%
Operating Margin-8.60%
Net Margin-6.94%
Debt/Equity0.09
Current Ratio3.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$358.0M$377.0M$316.0M$336.0M$349.0M
Operating Profit$9.0M$-85.0M$-109.0M$-43.0M$-30.0M
Net Profit$-6.0M$-84.0M$-102.0M$-36.0M$-23.0M
EPS$-0.28$-3.67$-4.42$-1.52$-0.85
Op Margin2.6%-22.6%-34.6%-12.7%-8.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$490.0M$405.0M$326.0M$296.0M$299.0M
Total Liabilities$119.0M$108.0M$121.0M$122.0M$106.0M
Cash$236.0M$187.0M$125.0M$114.0M$104.0M
Borrowings$27.0M$23.0M$22.0M$19.0M$17.0M

Latest News

Inogen Names Chief Operating Officer MT Newswires · Jul 1, 2026 Inogen Announces the Appointment of Andy Reding as Chief Operating Officer Business Wire · Jul 1, 2026 Here's Why You Should Retain Inogen Stock in Your Portfolio for Now Zacks · Jun 25, 2026 How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions Simply Wall St. · May 11, 2026 INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves Zacks · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$24.0M$-38.0M$-3.0M$6.0M$-11.0M
Investing Cash Flow$-39.0M$-32.0M$-86.0M$-31.0M$-37.0M
Financing Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$-4.0M
Net Cash Flow$24.0M$-49.0M$-62.0M$-8.0M$-12.0M
Free Cash Flow$0$-59.0M$-30.0M$-11.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.45
EV / EBITDA-13.21
FCF Yield-6.06%
Quick Ratio2.34
Interest Coverage—
Return 1Y-5.66%
Return 3Y-28.80%
Return 5Y-90.46%

Ownership

Insiders Held12.64%
Institutions Held77.54%
Institutions Float Held88.76%
Institutional HolderSharesReport Date
Blackrock Inc.1,647,0842026-03-31
Armistice Capital, LLC1,200,0002026-03-31
Acadian Asset Management. LLC1,083,4832026-03-31
Vanguard Capital Management LLC1,036,7052026-03-31
Ameriprise Financial, Inc.859,5432026-03-31

About Inogen, Inc

Inogen, Inc is led by CEO Kevin R. Smith, employs 766 people, headquartered in US, publicly traded since 2014.

Inogen, Inc (INGN) stock trades at $7.10 with a market capitalization of $188.42M. The stock is valued at a negative price-to-earnings (P/E) ratio of -6.57, reflecting a net loss over the last twelve months, price-to-book of 0.91, price-to-sales of 0.45. Over the past 52 weeks the stock has ranged between $5.04 and $9.13, and currently trades 22.2% below its 52-week high.

On profitability, Inogen, Inc generates a return on equity (ROE) of -13.17% (negative, reflecting a net loss), return on capital employed of -13.94%, an operating margin of -8.60%, a net profit margin of -6.94%.

Inogen, Inc by the numbers, 2016–2025

Between 2016 and 2025 Inogen, Inc reported revenue of $203.0M rising to $349.0M, a change of +71.9% across 10 years. Compounded, revenue has grown 2.5% a year over five years, -2.5% over three, 3.9% over the last twelve months. Net profit fell to $-23.0M.

Operating margin went from 11.3% in 2016 to -8.7% in 2025, a fall of 19.9 percentage points. The most recent net margin is -6.94%. On a trailing twelve-month basis to Jun '26, revenue is $354.0M and net profit $-24.0M.

Borrowings stand at $17.0M, cash from operations was $-11.0M in the latest year, positive in 7 of the last 10.

Return on equity has averaged -22.5% over five years, and was -12.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Inogen, Inc (INGN) — frequently asked questions

What is Inogen, Inc (INGN) stock price today?

Inogen, Inc (INGN) is currently trading at $7.10, up 0.85% today.

What is INGN P/E ratio?

Inogen, Inc's P/E ratio is -6.57. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is INGN return on equity (ROE)?

Inogen, Inc's return on equity (ROE) is -13.17%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Inogen, Inc's market cap?

Inogen, Inc has a market capitalization of $188.42M.

Does INGN pay a dividend?

Inogen, Inc is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does INGN carry?

Inogen, Inc has a debt-to-equity ratio of 0.09. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is INGN's profit margin?

Inogen, Inc reports a net profit margin of -6.94% — the share of revenue left after every cost, including tax and interest.

What sector is INGN in?

Inogen, Inc is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is INGN listed on?

Inogen, Inc trades on NASDAQ under the ticker INGN.

What is INGN's 52-week range?

Over the last year Inogen, Inc has traded between $5.04 and $9.13.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens INGN currently matches

On the figures above, Inogen, Inc passes the filters for 1 of our ready-made screens, among them Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Micro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.